The Diabetes Management Market Size accounted for USD 19.4 Billion in 2023 and is estimated to achieve a market size of USD 37.8 Billion by 2032 growing at a CAGR of 7.9% from 2024 to 2032.
Diabetes Management Market Highlights
- Global diabetes management market revenue is poised to garner USD 37.8 billion by 2032 with a CAGR of 7.9% from 2024 to 2032
- North America diabetes management market value occupied around USD 7.2 billion in 2023
- Asia-Pacific diabetes management market growth will record a CAGR of more than 9% from 2024 to 2032
- Among device type, the monitoring devices sub-segment generated notable revenue in 2023
- Based on application, the diabetes & blood glucose tracking apps sub-segment generated around significant market share in 2023
- Increasing focus on preventive healthcare and lifestyle interventions is a popular diabetes management market trend that fuels the industry demand
Diabetes is a metabolic disease in which the blood sugar levels of the body is increased for extended period. During last few years, there is significant increase in the prevalence of the diabetes which has led to increase in the demand for the various types of technology for diabetes. This technology includes glucose test strips, digital health/digital therapeutics, insulin pumps, continuous glucose monitoring (CGM), insulin pens, side effect management and diagnosis. Digitalization and development in the technology has led to the introduction of the advanced devices. A number of companies are involved in the development of the advanced devices which are used in the management of the diabetes.
Global Diabetes Management Market Dynamics
Market Drivers
- Increasing prevalence of diabetes worldwide
- Technological advancements in diabetes management devices
- Rising healthcare expenditure and government support
- Growing adoption of digital health solutions
Market Restraints
- Lack of awareness about diabetes management
- Limited access to skilled healthcare professionals
- High cost associated with advanced diabetes treatments
Market Opportunities
- Expansion in emerging markets with high diabetes burden
- Development of personalized medicine and therapies
- Integration of artificial intelligence in diabetes management
Diabetes Management Market Report Coverage
| Market |
Diabetes Management Market
|
| Diabetes Management Market Size 2022 |
USD 19.4 Billion |
| Diabetes Management Market Forecast 2032 |
USD 37.8 Billion |
| Diabetes Management Market CAGR During 2023 - 2032 |
7.9% |
| Diabetes Management Market Analysis Period |
2020 - 2032 |
Diabetes Management Market Base Year
|
2022 |
| Diabetes Management Market Forecast Data |
2023 - 2032 |
| Segments Covered |
By Device Type, By Therapeutics, By Application, By End-User, And By Geography
|
| Regional Scope |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Key Companies Profiled |
Johnson & Johnson, Dexcom, Insulet Corporation, Becton, Dickinson and Company, Medtronic, Roche Diagnostics, Novo Nordisk, Eli Lilly and Company, Abbott Laboratories, and Sanofi.
|
Report Coverage
|
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Covid-19 Analysis, Regulation Analysis |
Diabetes Management Market Insights
During last decade there is a significant increase in the prevalence of the diabetes. As per the WHO, diabetes affects around 422 million people worldwide, and it causes 1.5 million deaths each year. Increasing prevalence of the diabetes is the major driving factor for the growth of the market. Obese and smokers are more prone to diabetes. Increasing patient suffering from obesity and changing lifestyle of the people has catalyzed the growth of the technology for diabetes management market. Moreover, increased the demand for the better treatment option, increasing per capita income, increasing government support, increasing healthcare expenditure, and development in the technology have boosted the growth of the market during the diabetes management industry forecast period 2024-2032. However, lack of awakes among the people and limited availability of the skilled professionals are responsible for affecting the growth of the market negatively. In near future the market is expecting a healthy opportunity owing to the continuous increasing demand for the better technology.
Diabetes Management Market Segmentation
The worldwide market for diabetes management is split based on device type, therapeutics, application, end user, and geography.
Diabetes Management Device Types
- Monitoring Devices
- Blood Glucose Meters
- Lancets
- Blood Sampling Devices
- Diagnostic Devices
- Hemoglobin A1c
- Hemoglobin A1c Kits
- Hemoglobin A1c Meters
- Insulin Delivery Devices
- Insulin Pumps
- Insulin Pens
- Disposable Insulin Pens
- Insulin Syringes
- Reusable Insulin Pens
- Other Devices
- Artificial Pancreas
- Commercial Software
- Software Programs for Diabetes Monitoring
- Web Software
According to diabetes management industry analysis, the monitoring devices sector is the largest. Continuous glucose monitors (CGMs) and standard blood glucose meters are important tools for managing diabetes on a daily basis. The extensive use of these devices is motivated by their vital function in assisting patients in maintaining ideal blood sugar levels, hence avoiding problems. The rising prevalence of diabetes, combined with technical improvements such as real-time glucose monitoring, user-friendly interfaces, and integration with digital health platforms, has spurred demand. Furthermore, increased patient awareness of the significance of regular glucose monitoring, as well as the convenience provided by wearable devices, contribute to the monitoring devices segment's dominance in the market.
Diabetes Management Therapeutics
- Injectables
- Oral Drugs
- Metformin
- Sulfonylureas
- Alpha Glycosidase Inhibitors
- Dipeptidyl Inhibitors
- Meglitinides
- Thaizolidinediones
- Combination Medications
Oral drugs are the largest sector and it is expected to grow over the diabetes management market forecast period. This domination is fueled by the high frequency of Type 2 diabetes, which accounts for the vast majority of diabetes cases worldwide. Oral antidiabetic medications such metformin, sulfonylureas, DPP-4 inhibitors, and SGLT2 inhibitors are frequently used as the first line of treatment due to their efficacy, convenience of administration, and patient compliance. The growing prevalence of Type 2 diabetes, combined with an aging population and rising obesity rates, has increased demand for these drugs. Furthermore, advances in oral drug formulations and the introduction of new therapeutic classes have improved treatment outcomes and patient adherence, reinforcing the oral pharmaceuticals segment's dominant position in the industry.
Diabetes Management Applications
- Obesity
- Diet Management Apps
- Diabetes & Blood Glucose Tracking Apps
- Others
The diabetes & blood glucose tracking apps sector is predicted to be the most significant in the market. These apps enable patients to monitor and manage their blood sugar levels in real time, giving important information for efficient diabetes treatment. The rising prevalence of diabetes, combined with a growing emphasis on individualized healthcare, has fueled the popularity of these apps. Advances in mobile health technologies, integration with wearable devices, and user-friendly interfaces make these apps extremely accessible and convenient for daily usage. Furthermore, rising awareness of the significance of frequent blood glucose monitoring, as well as increased global smartphone use, contribute to the diabetes & blood glucose tracking apps segment's predicted dominance in the diabetes management industry.
Diabetes Management End-Users
- Specialty Diabetes Clinics
- Home Healthcare
- Others
The home healthcare category is expected to lead the diabetes management industry. This expansion is being driven by an increase in preferences for managing chronic illnesses like diabetes at home, which provides convenience, tailored treatment, and regular health monitoring without the need for frequent clinic visits. Patients benefit from services such as expert nursing care, medication management, and self-management training. Telemedicine and remote monitoring advancements improve accessibility and provide real-time help for diabetes control at home. With a growing aging population and rising diabetes incidence globally, demand for specialized home healthcare services is increasing, highlighting the segment's critical role in influencing the diabetes management market.
Diabetes Management Market Regional Outlook
North America
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- India
- Japan
- China
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
The Middle East & Africa
- South Africa
- GCC Countries
- Rest of the Middle East & Africa (ME&A)
Diabetes Management Market Regional Analysis
Regionally, the technology for diabetes management industry is segmented into North America, Europe, Asia-Pacific and Latin America, Middle East & Africa.
In terms of diabetes management market analysis, North America is expected to dominate the technology for industry owing to the presence of huge patient pool, advancement in technology, and high spending on healthcare. According to WHO, 9.2% of the American population were suffering from diabetes. Additionally, presence of a huge number of players and increasing government support will fuel the growth of the market. Europe accounts for the second leading market in the forecast period followed by the Asia Pacific. Presences of huge investment in European region, huge government support, and well developed economies have driven the growth of the European market.
Asia-Pacific technology for expected to be the fastest growth during the diabetes management market forecast period of 2024-2032. The growth is majorly attributed due to presence of huge diabetic and obese patients of the region. According to the International Diabetes Federation (IDF), approximately 60% of total global diabetic population was present in Asia of which over 114 million are in China alone. Moreover, increasing government support and increasing per capita income have fueled the growth of the Asia-Pacific market. LAMEA region is expecting a steady growth during the forecast period.
Diabetes Management Market Players
Some of the top diabetes management companies offered in our report includes Johnson & Johnson, Dexcom, Insulet Corporation, Becton, Dickinson and Company, Medtronic, Roche Diagnostics, Novo Nordisk, Eli Lilly and Company, Abbott Laboratories, and Sanofi.
CHAPTER 1. Industry Overview of Diabetes Management Market
1.1. Definition and Scope
1.1.1. Definition of Diabetes Management
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Diabetes Management Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Diabetes Management Market By Device Type
1.2.3. Diabetes Management Market By Therapeutics
1.2.4. Diabetes Management Market By Application
1.2.5. Diabetes Management Market By End User
1.2.6. Diabetes Management Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Diabetes Management Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Diabetes Management Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2023
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2023
4.2. R&D Status of Major Manufacturers in 2023
CHAPTER 5. Diabetes Management Market By Device Type
5.1. Introduction
5.2. Diabetes Management Revenue By Device Type
5.2.1. Diabetes Management Revenue (USD Million) and Forecast, By Device Type, 2020-2032
5.2.2. Monitoring Devices
5.2.2.1. Monitoring Devices Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.2.2. Blood Glucose Meters
5.2.2.2.1. Blood Glucose Meters Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.2.3. Lancets
5.2.2.3.1. Lancets Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.2.4. Blood Sampling Devices
5.2.2.4.1. Blood Sampling Devices Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3. Diagnostic Devices
5.2.3.1. Diagnostic Devices Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3.2. Hemoglobin A1c
5.2.3.2.1. Hemoglobin A1c Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3.3. Hemoglobin A1c Kits
5.2.3.3.1. Hemoglobin A1c Kits Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3.4. Hemoglobin A1c Meters
5.2.3.4.1. Hemoglobin A1c Meters Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.4. Insulin Delivery Devices
5.2.4.1. Insulin Delivery Devices Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.4.2. Insulin Pumps
5.2.4.2.1. Insulin Pumps Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.4.3. Insulin Pens
5.2.4.3.1. Insulin Pens Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.4.4. Disposable Insulin Pens
5.2.4.4.1. Disposable Insulin Pens Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.4.5. Insulin Syringes
5.2.4.5.1. Insulin Syringes Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.4.6. Reusable Insulin Pens
5.2.4.6.1. Reusable Insulin Pens Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.5. Other Devices
5.2.5.1. Other Devices Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.5.2. Artificial Pancreas
5.2.5.2.1. Artificial Pancreas Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.5.3. Commercial Software
5.2.5.3.1. Commercial Software Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.5.4. Software Programs for Diabetes Monitoring
5.2.5.4.1. Software Programs for Diabetes Monitoring Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.5.5. Web Software
5.2.5.5.1. Web Software Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 6. Diabetes Management Market By Therapeutics
6.1. Introduction
6.2. Diabetes Management Revenue By Therapeutics
6.2.1. Diabetes Management Revenue (USD Million) and Forecast, By Therapeutics, 2020-2032
6.2.2. Injectables
6.2.2.1. Injectables Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.2.2. Insulin
6.2.2.2.1. Insulin Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.2.3. Exenatide
6.2.2.3.1. Exenatide Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.3. Oral Drugs
6.2.3.1. Oral Drugs Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.3.2. Metformin
6.2.3.2.1. Metformin Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.3.3. Sulfonylureas
6.2.3.3.1. Sulfonylureas Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.3.4. Alpha glycosidase Inhibitors
6.2.3.4.1. Alpha glycosidase Inhibitors Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.3.5. Dipeptidyl Inhibitors
6.2.3.5.1. Dipeptidyl Inhibitors Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.3.6. Meglitinides
6.2.3.6.1. Meglitinides Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.3.7. Thaizolidinediones
6.2.3.7.1. Thaizolidinediones Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.3.8. Combination Medications
6.2.3.8.1. Combination Medications Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 7. Diabetes Management Market By Application
7.1. Introduction
7.2. Diabetes Management Revenue By Application
7.2.1. Diabetes Management Revenue (USD Million) and Forecast, By Application, 2020-2032
7.2.2. Obesity
7.2.2.1. Obesity Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.3. Diet Management Apps
7.2.3.1. Diet Management Apps Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.4. Diabetes & Blood Glucose Tracking Apps
7.2.4.1. Diabetes & Blood Glucose Tracking Apps Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.5. Others
7.2.5.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 8. Diabetes Management Market By End User
8.1. Introduction
8.2. Diabetes Management Revenue By End User
8.2.1. Diabetes Management Revenue (USD Million) and Forecast, By End User, 2020-2032
8.2.2. Specialty Diabetes Clinics
8.2.2.1. Specialty Diabetes Clinics Market Revenue (USD Million) and Growth Rate (%), 2020-2032
8.2.3. Home Healthcare
8.2.3.1. Home Healthcare Market Revenue (USD Million) and Growth Rate (%), 2020-2032
8.2.4. Others
8.2.4.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 9. North America Diabetes Management Market By Country
9.1. North America Diabetes Management Market Overview
9.2. U.S.
9.2.1. U.S. Diabetes Management Revenue (USD Million) and Forecast By Therapeutics, 2020-2032
9.2.2. U.S. Diabetes Management Revenue (USD Million) and Forecast By Device Type, 2020-2032
9.2.3. U.S. Diabetes Management Revenue (USD Million) and Forecast By Application, 2020-2032
9.2.4. U.S. Diabetes Management Revenue (USD Million) and Forecast By End User, 2020-2032
9.3. Canada
9.3.1. Canada Diabetes Management Revenue (USD Million) and Forecast By Therapeutics, 2020-2032
9.3.2. Canada Diabetes Management Revenue (USD Million) and Forecast By Device Type, 2020-2032
9.3.3. Canada Diabetes Management Revenue (USD Million) and Forecast By Application, 2020-2032
9.3.4. Canada Diabetes Management Revenue (USD Million) and Forecast By End User, 2020-2032
9.4. North America PEST Analysis
CHAPTER 10. Europe Diabetes Management Market By Country
10.1. Europe Diabetes Management Market Overview
10.2. U.K.
10.2.1. U.K. Diabetes Management Revenue (USD Million) and Forecast By Therapeutics, 2020-2032
10.2.2. U.K. Diabetes Management Revenue (USD Million) and Forecast By Device Type, 2020-2032
10.2.3. U.K. Diabetes Management Revenue (USD Million) and Forecast By Application, 2020-2032
10.2.4. U.K. Diabetes Management Revenue (USD Million) and Forecast By End User, 2020-2032
10.3. Germany
10.3.1. Germany Diabetes Management Revenue (USD Million) and Forecast By Therapeutics, 2020-2032
10.3.2. Germany Diabetes Management Revenue (USD Million) and Forecast By Device Type, 2020-2032
10.3.3. Germany Diabetes Management Revenue (USD Million) and Forecast By Application, 2020-2032
10.3.4. Germany Diabetes Management Revenue (USD Million) and Forecast By End User, 2020-2032
10.4. France
10.4.1. France Diabetes Management Revenue (USD Million) and Forecast By Therapeutics, 2020-2032
10.4.2. France Diabetes Management Revenue (USD Million) and Forecast By Device Type, 2020-2032
10.4.3. France Diabetes Management Revenue (USD Million) and Forecast By Application, 2020-2032
10.4.4. France Diabetes Management Revenue (USD Million) and Forecast By End User, 2020-2032
10.5. Spain
10.5.1. Spain Diabetes Management Revenue (USD Million) and Forecast By Therapeutics, 2020-2032
10.5.2. Spain Diabetes Management Revenue (USD Million) and Forecast By Device Type, 2020-2032
10.5.3. Spain Diabetes Management Revenue (USD Million) and Forecast By Application, 2020-2032
10.5.4. Spain Diabetes Management Revenue (USD Million) and Forecast By End User, 2020-2032
10.6. Rest of Europe
10.6.1. Rest of Europe Diabetes Management Revenue (USD Million) and Forecast By Therapeutics, 2020-2032
10.6.2. Rest of Europe Diabetes Management Revenue (USD Million) and Forecast By Device Type, 2020-2032
10.6.3. Rest of Europe Diabetes Management Revenue (USD Million) and Forecast By Application, 2020-2032
10.6.4. Rest of Europe Diabetes Management Revenue (USD Million) and Forecast By End User, 2020-2032
10.7. Europe PEST Analysis
CHAPTER 11. Asia Pacific Diabetes Management Market By Country
11.1. Asia Pacific Diabetes Management Market Overview
11.2. China
11.2.1. China Diabetes Management Revenue (USD Million) and Forecast By Therapeutics, 2020-2032
11.2.2. China Diabetes Management Revenue (USD Million) and Forecast By Device Type, 2020-2032
11.2.3. China Diabetes Management Revenue (USD Million) and Forecast By Application, 2020-2032
11.2.4. China Diabetes Management Revenue (USD Million) and Forecast By End User, 2020-2032
11.3. Japan
11.3.1. Japan Diabetes Management Revenue (USD Million) and Forecast By Therapeutics, 2020-2032
11.3.2. Japan Diabetes Management Revenue (USD Million) and Forecast By Device Type, 2020-2032
11.3.3. Japan Diabetes Management Revenue (USD Million) and Forecast By Application, 2020-2032
11.3.4. Japan Diabetes Management Revenue (USD Million) and Forecast By End User, 2020-2032
11.4. India
11.4.1. India Diabetes Management Revenue (USD Million) and Forecast By Therapeutics, 2020-2032
11.4.2. India Diabetes Management Revenue (USD Million) and Forecast By Device Type, 2020-2032
11.4.3. India Diabetes Management Revenue (USD Million) and Forecast By Application, 2020-2032
11.4.4. India Diabetes Management Revenue (USD Million) and Forecast By End User, 2020-2032
11.5. Australia
11.5.1. Australia Diabetes Management Revenue (USD Million) and Forecast By Therapeutics, 2020-2032
11.5.2. Australia Diabetes Management Revenue (USD Million) and Forecast By Device Type, 2020-2032
11.5.3. Australia Diabetes Management Revenue (USD Million) and Forecast By Application, 2020-2032
11.5.4. Australia Diabetes Management Revenue (USD Million) and Forecast By End User, 2020-2032
11.6. South Korea
11.6.1. South Korea Diabetes Management Revenue (USD Million) and Forecast By Therapeutics, 2020-2032
11.6.2. South Korea Diabetes Management Revenue (USD Million) and Forecast By Device Type, 2020-2032
11.6.3. South Korea Diabetes Management Revenue (USD Million) and Forecast By Application, 2020-2032
11.6.4. South Korea Diabetes Management Revenue (USD Million) and Forecast By End User, 2020-2032
11.7. Rest of Asia-Pacific
11.7.1. Rest of Asia-Pacific Diabetes Management Revenue (USD Million) and Forecast By Therapeutics, 2020-2032
11.7.2. Rest of Asia-Pacific Diabetes Management Revenue (USD Million) and Forecast By Device Type, 2020-2032
11.7.3. Rest of Asia-Pacific Diabetes Management Revenue (USD Million) and Forecast By Application, 2020-2032
11.7.4. Rest of Asia-Pacific Diabetes Management Revenue (USD Million) and Forecast By End User, 2020-2032
11.8. Asia Pacific PEST Analysis
CHAPTER 12. Latin America Diabetes Management Market By Country
12.1. Latin America Diabetes Management Market Overview
12.2. Brazil
12.2.1. Brazil Diabetes Management Revenue (USD Million) and Forecast By Therapeutics, 2020-2032
12.2.2. Brazil Diabetes Management Revenue (USD Million) and Forecast By Device Type, 2020-2032
12.2.3. Brazil Diabetes Management Revenue (USD Million) and Forecast By Application, 2020-2032
12.2.4. Brazil Diabetes Management Revenue (USD Million) and Forecast By End User, 2020-2032
12.3. Mexico
12.3.1. Mexico Diabetes Management Revenue (USD Million) and Forecast By Therapeutics, 2020-2032
12.3.2. Mexico Diabetes Management Revenue (USD Million) and Forecast By Device Type, 2020-2032
12.3.3. Mexico Diabetes Management Revenue (USD Million) and Forecast By Application, 2020-2032
12.3.4. Mexico Diabetes Management Revenue (USD Million) and Forecast By End User, 2020-2032
12.4. Rest of Latin America
12.4.1. Rest of Latin America Diabetes Management Revenue (USD Million) and Forecast By Therapeutics, 2020-2032
12.4.2. Rest of Latin America Diabetes Management Revenue (USD Million) and Forecast By Device Type, 2020-2032
12.4.3. Rest of Latin America Diabetes Management Revenue (USD Million) and Forecast By Application, 2020-2032
12.4.4. Rest of Latin America Diabetes Management Revenue (USD Million) and Forecast By End User, 2020-2032
12.5. Latin America PEST Analysis
CHAPTER 13. Middle East & Africa Diabetes Management Market By Country
13.1. Middle East & Africa Diabetes Management Market Overview
13.2. GCC
13.2.1. GCC Diabetes Management Revenue (USD Million) and Forecast By Therapeutics, 2020-2032
13.2.2. GCC Diabetes Management Revenue (USD Million) and Forecast By Device Type, 2020-2032
13.2.3. GCC Diabetes Management Revenue (USD Million) and Forecast By Application, 2020-2032
13.2.4. GCC Diabetes Management Revenue (USD Million) and Forecast By End User, 2020-2032
13.3. South Africa
13.3.1. South Africa Diabetes Management Revenue (USD Million) and Forecast By Therapeutics, 2020-2032
13.3.2. South Africa Diabetes Management Revenue (USD Million) and Forecast By Device Type, 2020-2032
13.3.3. South Africa Diabetes Management Revenue (USD Million) and Forecast By Application, 2020-2032
13.3.4. South Africa Diabetes Management Revenue (USD Million) and Forecast By End User, 2020-2032
13.4. Rest of Middle East & Africa
13.4.1. Rest of Middle East & Africa Diabetes Management Revenue (USD Million) and Forecast By Therapeutics, 2020-2032
13.4.2. Rest of Middle East & Africa Diabetes Management Revenue (USD Million) and Forecast By Device Type, 2020-2032
13.4.3. Rest of Middle East & Africa Diabetes Management Revenue (USD Million) and Forecast By Application, 2020-2032
13.4.4. Rest of Middle East & Africa Diabetes Management Revenue (USD Million) and Forecast By End User, 2020-2032
13.5. Middle East & Africa PEST Analysis
CHAPTER 14. Player Analysis Of Diabetes Management Market
14.1. Diabetes Management Market Company Share Analysis
14.2. Competition Matrix
14.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
14.2.2. New Product Launches and Product Enhancements
14.2.3. Mergers And Acquisition In Global Diabetes Management Market
14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 15. Company Profile
15.1. Johnson & Johnson
15.1.1. Company Snapshot
15.1.2. Business Overview
15.1.3. Financial Overview
15.1.3.1. Revenue (USD Million), 2023
15.1.3.2. Johnson & Johnson 2023 Diabetes Management Business Regional Distribution
15.1.4. Product /Service and Specification
15.1.5. Recent Developments & Business Strategy
15.2. Dexcom
15.3. Insulet Corporation
15.4. Becton
15.5. Dickinson and Company
15.6. Medtronic
15.7. Roche Diagnostics
15.8. Novo Nordisk
15.9. Eli Lilly and Company
15.10. Abbott Laboratories
15.11. Sanofi
